BlackRock, Inc. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 4:23 pm Purchase |
2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS |
BlackRock Inc. BLK |
10,011,391 7.200% |
10,011,391 (New Position) |
Filing |